• Explore /
  • Poster
  • / Effect of body mass index (BMI) on efficacy of immune checkpoint inhibitors (ICIs) in patients with metastatic urothelial carcinoma (mUC) in a real-world setting.

Effect of body mass index (BMI) on efficacy of immune checkpoint inhibitors (ICIs) in patients with metastatic urothelial carcinoma (mUC) in a real-world setting.

Abstract Poster

Authors

null

David Lynn

Cleveland Clinic, Cleveland, OH

David Lynn , Charbel Hobeika , Ubenthira Patgunarajah , Scott Dawsey , Nikhil Pramod , Wei Wei , Monica Nair , Kimberly Maroli , Allison Martin , Moshe Chaim Ornstein , Christopher Eing Wee , Timothy D. Gilligan , Amanda Nizam , Amanda Bonham , Omar Y. Mian , Paul G. Pavicic Jr., C. Marcela Diaz-Montero , Shilpa Gupta

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2024 ASCO Genitourinary Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session B: Urothelial Carcinoma

Track

Urothelial Carcinoma

Sub Track

Quality of Care/Quality Improvement and Real-World Evidence

Citation

J Clin Oncol 42, 2024 (suppl 4; abstr 571)

DOI

10.1200/JCO.2024.42.4_suppl.571

Abstract #

571

Poster Bd #

E20

Abstract Disclosures

Similar Posters

First Author: Nikhil Pramod

First Author: Amanda Nizam

First Author: Scott Dawsey

First Author: Nikhil Pramod